InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Iwicki Mark T, Director. Officer active across 5 companies, notably Akero Therapeutics, Inc.. Aggregated, 22 filings have been published. Split: 0 buy · 11 sells. Total volume traded: €431k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 12 December 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Iwicki Mark T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
73,576 shares@ US$97.0096.5% of flowCommon SharesSEC:0001193125-25-317936:0
9,398 sharesCommon StockSEC:0001193125-25-312115:0
154,894 shares@ US$0.8132.3% of flowCommon StockSEC:0001415537-25-000004:0
128,631 sharesCommon StockSEC:0001415889-25-021822:0
13,227 shares@ US$4.0120.2% of flowCommon StockSEC:0001415889-25-018317:0
2,450 shares0Common StockSEC:0001415889-25-017615:0
9,398 shares0Common StockSEC:0000950170-25-082309:0
10,866 shares@ US$3.7419.8% of flowCommon StockSEC:0001104659-25-056986:0
10,866 shares@ US$3.7424.7% of flowCommon StockSEC:0001415889-25-015677:0
22,100 shares0Common StockSEC:0001415889-25-001060:0
15,168 shares@ US$4.7561.9% of flowCommon StockSEC:0001415889-24-018374:0
7,392 shares@ US$6.0938.1% of flowCommon StockSEC:0001415889-24-015222:0
14,300 shares0Common StockSEC:0001415889-24-000769:0
158,873 shares0Common StockSEC:0001415889-23-010281:0
71,715 sharesCommon StockSEC:0001415889-23-009133:0
36,944 shares@ US$6.57100.0% of flowCommon SharesSEC:0001209191-23-024393:0
41,700 shares0Common StockSEC:0001415889-23-000636:0
561 shares@ US$6.521.9% of flowCommon StockSEC:0001415889-22-010878:0
7,975 shares@ US$0.370.018% mcap1.5% of flowCommon StockSEC:0001415889-22-007059:0
9,518 shares@ US$1.300.071% mcap6.0% of flowCommon StockSEC:0001415889-22-000402:0
27,598 shares@ US$1.800.28% mcap23.3% of flowCommon StockSEC:0001415889-21-005009:0
7,586 shares@ US$5.7737.9% of flowCommon StockSEC:0001415889-21-003256:0
22 of 22 declarations
About Iwicki Mark T
Iwicki Mark T is a Director at KALA BIO, Inc., Merus N.V., Akero Therapeutics, Inc. and Third Harmonic Bio, Inc., and Chief Executive Officer at Kala Pharmaceuticals, Inc. Across the 22 filings, the recent sampled filings show sales of EUR 430952 between 2021-06-29 and 2025-12-12, with the modal transaction nature indicated as Cession.
